Bioxytran (BIXT) FCF Margin (QoQ) (2010 - 2018)
Bioxytran (BIXT) FCF Margin (QoQ) (2010 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Bioxytran | 2.52 Mn | 2.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 63.00 |
| Mar 31, 2018 | -94.00 |
| Dec 31, 2017 | -2,091.00 |
| Sep 30, 2017 | 2,986.00 |
| Jun 30, 2017 | 9,954.00 |
| Mar 31, 2017 | -9,495.00 |
| Dec 31, 2016 | -930.00 |
| Sep 30, 2016 | 1,721.00 |
| Jun 30, 2016 | 3,927.00 |
| Mar 31, 2016 | -6,101.00 |
| Dec 31, 2015 | -1,881.00 |
| Sep 30, 2015 | 3,229.00 |
| Jun 30, 2015 | -734.00 |
| Mar 31, 2015 | -14,834.00 |
| Dec 31, 2014 | 12,246.00 |
| Sep 30, 2014 | 14,317.00 |
| Jun 30, 2014 | -14,148.00 |
| Mar 31, 2014 | 1,581.00 |
| Dec 31, 2013 | 27,002.00 |
| Sep 30, 2013 | -25,021.00 |